Stay updated with breaking news from Nasdaq Itos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ITeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) was the recipient of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 1,420,000 shares, a decrease of 6.0% from the June 30th total of 1,510,000 shares. Based on an average daily trading volume, of 284,300 […]
Endurant Capital Management LP acquired a new position in iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Rating) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 21,041 shares of the company’s stock, valued at approximately $411,000. Other hedge funds also recently made changes to their positions in the company. American International Group Inc. raised its […]
Tang Capital Management LLC trimmed its position in shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Rating) by 76.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 216,700 shares of the company’s stock after selling 720,800 shares during the […]
ITeos Therapeutics, Inc. (NASDAQ:ITOS – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,780,000 shares, an increase of 6.6% from the April 30th total of 1,670,000 shares. Approximately 6.1% of the company’s stock are sold short. Based […]
ITeos Therapeutics, Inc. (NASDAQ:ITOS – Get Rating)’s share price traded down 6.3% during mid-day trading on Tuesday . The stock traded as low as $16.51 and last traded at $16.91. 145,109 shares traded hands during mid-day trading, a decline of 45% from the average session volume of 264,273 shares. The stock had previously closed at […]